- Home
- People
- CLINUVEL news
Nasdaq TradeTalks Interview
CLINUVEL’s Managing Director, Dr Philippe Wolgen, speaks with Jill Malandrino on Nasdaq TradeTalks, 26 October 2021.PeopleDr Pilar Bilbao discusses possible solutions for stroke patients
Ischaemic strokes cause irreversible damage. They begin suddenly and the damage escalates if the stroke is not treated quickly.Finance & investingInsider Insights III: Willem Blijdorp, Challenges & the Future
In the third and final part of this Insider Insights series, CLINUVEL’s Chair Willem Blijdorp and Professor Kitty Koelemeijer discuss navigating contemporary challenges within a public company...Finance & investingInsider Insights II: Willem Blijdorp, CLINUVEL’s Products, People & Social Purpose
In this second of three Insider Insights, CLINUVEL’s Chair Willem Blijdorp and Professor Kitty Koelemeijer explore the products, people and social purpose of the ASX-listed Group (CUV).
- R&D
- People
Dr Pilar Bilbao discusses possible solutions for stroke patients
Ischaemic strokes cause irreversible damage. They begin suddenly and the damage escalates if the stroke is not treated quickly.CLINUVEL newsUnderstanding the effects of stroke
CLINUVEL has today announced that its drug afamelanotide was well tolerated by the first three arterial ischaemic stroke (AIS) patients enrolled in a world first clinical trial (CUV801). Watch our new video explaining the pathology and treatment of stroke.PublicationsHas COVID-19 Had an Effect on Sun Protection Behaviours?
Quarantine fatigue amongst the general public may result in a higher incidence rate of sunburn, according to a recent analysis of...R&DPublication brief: Wood’s Light (Wood’s Lamp)
The Wood’s Lamp – invented in 1903 by Baltimore physicist Robert W Wood - is a source of long wave ultraviolet...
- Publications
- Publications
The Weekend Effect – A Worrying Truth or Myth?
Reduced staff over the weekends is the norm for many retail shops, but what about in healthcare? A number of reviews have...PublicationsIs skin cancer in your job description?
Those of us working from offices, or our own homes, aren’t expecting danger pay.  However, what about those who have jobs that heighten the risk of getting skin...PublicationsTomatoes and carrots… photoprotection from within?
Most of us have been spun a myth that eating our crusts will make our hair shiny, and that we should...PublicationsHas COVID-19 Had an Effect on Sun Protection Behaviours?
Quarantine fatigue amongst the general public may result in a higher incidence rate of sunburn, according to a recent analysis of...
- Finance & investing
- CLINUVEL news
CLINUVEL PHARMACEUTICALS – Annual General Meeting 2021
On November 10th 2021 CLINUVEL PHARMACEUTICALS live streamed its 2021 Annual General MeetingCLINUVEL newsMorgans Scone Value in the Vines Annual Investor Conference 22nd October 2021
Fireside chat hosted by Morgans Scone, featuring Dr. Phillipe Wolgen CEO & Malcolm Bull IR of Clinuvel Pharmaceuticals Limited (CUV:ASX).CLINUVEL newsNasdaq TradeTalks Interview
CLINUVEL’s Managing Director, Dr Philippe Wolgen, speaks with Jill Malandrino on Nasdaq TradeTalks, 26 October 2021.AnnouncementsCLINUVEL Investor Webinar October 2021
CLINUVEL’s Head of Investor Relations, Malcolm Bull, and Managing Director, Dr Philippe Wolgen, discuss the business and the year ahead.